Red Cell Lysis Buffer Application Versus Conventional Sample Processing in EUS-FNB
Pancreatic Diseases
About this trial
This is an interventional diagnostic trial for Pancreatic Diseases focused on measuring EUS-FNB, sample processing, solid pancreatic lesion
Eligibility Criteria
Inclusion Criteria: 18 to 80 years old; Solid pancreatic lesions confirmed by clinical and CT/MRI/ PET imaging. Signed written informed consent Exclusion Criteria: Contraindication of EUS-guide procedure or technical infeasibility (e.g.,coagulation disorder, anatomical changes, large vessels along the puncture path) Pregnant Patient is enrolled in any other clinical protocol or investigational trial
Sites / Locations
- Changhai Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Red cell lysis buffer (RCLB) group
conventional group
Patients assigned to this group will receive EUS-FNB as routine. The obtained tissue will be processed with red cell lysis buffer and underwent histological evaluation.
Patients assigned to this group will receive EUS-FNB as routine. The obtained tissue will be fixed with formalin as usual and underwent histological evaluation.